Clinical Trials Logo

Cognitive Dysfunction clinical trials

View clinical trials related to Cognitive Dysfunction.

Filter by:

NCT ID: NCT03636074 Completed - Clinical trials for Cognitive Dysfunction

Effects of Hypothermia on Delayed Neurocognitive Recovery (DNR): an Observational Trial Among Patients Undergoing Cardiac-Surgery

DNR
Start date: January 7, 2020
Phase:
Study type: Observational

Post-operative cognitive dysfunction is a common disease in patient undergoing general anaesthesia, especially in older patients. No correlations have been yet studied between intraoperative hypothermia and incidence of Delayed Neurocognitive Recovery. Investigators are going to estimate the Relative Risk of Hypothermia and emergence of Post-operative cognitive dysfunction in cardiac-surgery patients.

NCT ID: NCT03631238 Completed - Clinical trials for Hypercholesterolemia

The Dual Impact of Homocysteine and Cholesterol on Cognitive Functions

Start date: January 15, 2018
Phase:
Study type: Observational

The study evaluates if the relationship between total serum cholesterol is dependent on the total serum homocysteine. Fasting blood samples will taken from participants and two batteries of cognitive scales will be used to asses any cognitive decline.

NCT ID: NCT03630419 Completed - Alzheimer Disease Clinical Trials

Specialized Food Plan Based on Individual Physiological Comprehensive Body Assessments Accompanied With Cellular Repair Therapy to Decrease Inflammation Cognitively Impaired Patients

Start date: February 10, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

Diet plays a large role in inflammation, oxidative stress and cognition; however, every person's body type, resting metabolic rate, BMI, and inflammation levels vary. Through performing physiological and comprehensive cellular testing through bio-impedance, allows this study to create personalized diet plans for each subject's body type. Cellular repair therapy has also been known to improve cellular health and inflammation. Through decreasing inflammation and improving oxidative stress, cognition in those with MCI and AD could improve.

NCT ID: NCT03629912 Completed - Hypertension Clinical Trials

Bingocize: A Novel Mobile Application for Older Adult Health

Bingocize
Start date: August 13, 2018
Phase: N/A
Study type: Interventional

This study tests the effectiveness of using a new mobile application (Bingocize®) to improve older adults' (a) adherence to an engaging exercise program, and (b) aspects of functional performance, health knowledge, dietary habits, and cognition.

NCT ID: NCT03624387 Completed - Clinical trials for Cognitive Impairment

Geriatric Inclusive Art: Effects of Painting Sessions on Older In-patients With Cognitive Decline

GIA
Start date: January 2017
Phase: N/A
Study type: Interventional

Geriatric Inclusive Art (GIA) painting activity is a new form of art therapy, which has been adapted for older adults hospitalized in medical wards. GIA painting sessions have been associated with a decrease of in-hospital mortality and length of stay, particularly in patients with cognitive impairment. Preservation of a stable health status as well as functionality in activities of daily living of older inpatients is a primary objective of care management, in order to avoid deconditioning, long hospital stays and related higher costs.

NCT ID: NCT03623477 Completed - Schizophrenia Clinical Trials

Can Cognitive Training Decrease Reactive Aggression?

Start date: August 16, 2016
Phase: N/A
Study type: Interventional

The purpose of the study is to examine the effects of cognitive training on emotion regulation, impulse control, and aggression in people with schizophrenia. The study compares a combination of computerized cognitive remediation and social cognition training (CRT+SCT) to cognitive remediation alone (CRT). Study outcomes include multiple measures of aggression, emotion regulation, impulse control, cognition, and symptoms.

NCT ID: NCT03621540 Completed - Schizophrenia Clinical Trials

Augmentation of Working Memory Training With Transcranial Direct Current Stimulation in Patients With Schizophrenia

Start date: April 20, 2018
Phase: N/A
Study type: Interventional

Cognitive impairment is a core symptom of schizophrenia and is in a large part responsible for the poor psychosocial outcome of the disorder. The use of non-invasive brain stimulation techniques as a therapeutic option is just commencing for neuropsychiatric patients. Concerning healthy subjects the investigators have previously shown that anodal tDCS to the right dorsolateral prefrontal cortex (DLPFC) parallel to working memory training can sustainingly enhance performance in a spatial n-back task. Additionally, first translational experiments regarding the use of anodal tDCS to improve working memory (WM) in patients with schizophrenia rendered promising results. On those grounds, the investigators now test the hypothesis that anodal tDCS to the right DLPFC can augment working memory training in patients with schizophrenia.

NCT ID: NCT03620968 Completed - Clinical trials for Postoperative Cognitive Dysfunction

Implementation of a Cognitive Training Program to Reduce the Risk of Postoperative Cognitive Dysfunction

Start date: September 10, 2018
Phase: N/A
Study type: Interventional

Background: The postoperative cognitive dysfunction (POCD) is a frequent complication, often underestimated and leads to a negative impact on the quality of life for patients and their families. Objective: Measure the effectiveness of the cognitive training in reducing POCD in patients 55 and 70 years old undergoing elective non cardiac surgery with a degree II-III (medium-high) in "Centro Médico Teknon" Barcelona, during 2017-2018. Methodology: Randomized control clinical trial. The anticipate sample size is approximately 225, 75 in each group. Cognitive training performed at different stages of the perioperative period. Measure the cognitive function through a battery of neuropsychological tests during the preoperative (10 days pre-surgery) and postoperative (at 3 - 30 and 90 days post-surgery). Data analysis: SPSS 22, descriptive and inferential analysis: Chi-square, Student's t-test, ANOVA and Pearson correlation (p<0,05). Limitations: Loss for non-intervention and loss of follow-up. Applicability: Strategy to improve the quality of life patients and reduce socioeconomic costs associated.

NCT ID: NCT03602768 Completed - Aging Clinical Trials

Evaluation of the Online Memory & Aging Program and Online Goal Management Training

Start date: June 18, 2018
Phase: N/A
Study type: Interventional

The current study is designed to test the effectiveness of online programs for memory and executive functions in healthy aging. The investigators are testing online adaptations of two cognitive interventions that have been extensively studied, validated, and implemented in clinical settings: The Memory & Aging Program (MAP) targets normal memory change in healthy aging, and Goal Management Training (GMT) targets executive functioning deficits in a variety of cognitive and neurological conditions including healthy aging. Both programs combine psycho-education, targeted skills training and clinical support to empower participants with knowledge and strategies to harness their cognitive faculties. These programs are being tested against a waitlist control as well as against a commercial/research brain training platform (Cambridge Brain Sciences) in a design comparing performance on memory and executive functioning measures before and after the interventions/controls. The main hypothesis is that MAP will lead to memory-specific improvements above control conditions, whereas GMT will lead to greater improvements in measures of executive functions relative to controls.

NCT ID: NCT03601169 Completed - Depression Clinical Trials

Comparison of MMFS Dosages in Older Adults

Start date: July 23, 2018
Phase: Phase 2
Study type: Interventional

This study is designed to compare the effectiveness of different doses of brain health supplement MMFS relative to placebo on cognition, mood, and sleep quality.